CXCR4 and non-small cell lung carcinoma: In the group of patients with other organ metastases, CXCR4 overexpression was observed in 27 samples of NSCLC tissue (73.0%), which was significantly higher compared with that of patients without metastases (14.7%; P<0.001; Table III).